Lingdan Chen
Impact in
-
- Eicosanoids and Hypertension Pharmacology
-
- Cancer-related molecular mechanisms research
- Cancer Genomics and Diagnostics
- MicroRNA in disease regulation
Papers in
-
- Chronic Obstructive Pulmonary Disease (COPD) Research 4
- Pulmonary Hypertension Research and Treatments 2
- Respiratory Support and Mechanisms 1
-
- Angiogenesis and VEGF in Cancer 2
- Co-authors
- Wenju Lu (11 shared papers)He-Sheng Luo (1 shared paper)Baoping Yu (1 shared paper)Mingjie Yuan (4 shared papers)Mahinur Bakri (2 shared papers)Weiwei Xiao (1 shared paper)Zhun Sun (1 shared paper)Ping‐Hong Zhou (1 shared paper)
- Journals
- Biochemical and Biophysical Research Communications (2 papers)Bioscience Reports (2 papers)Chinese Journal of Natural Medicines (1 paper)Clinical and Translational Medicine (1 paper)Clinical Infectious Diseases (1 paper)
- Partner nations
- ChinaUnited StatesNetherlands
In The Last Decade
Lingdan Chen
14 papers receiving 271 citations
Peers
Comparison fields: 5 of 62
- Biochemistry 33
- Cancer Research 37
- Gastroenterology 12
- Immunology 42
- Pharmacology 15
Countries citing papers authored by Lingdan Chen
This map shows the geographic impact of Lingdan Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingdan Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingdan Chen more than expected).
Fields of papers citing papers by Lingdan Chen
This network shows the impact of papers produced by Lingdan Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingdan Chen. The network helps show where Lingdan Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Lingdan Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 85 | |
| 2 | 2008 | 39 | |
| 3 | 2012 | 31 | |
| 4 | 2018 | 23 | |
| 5 | 2019 | 18 | |
| 6 | 2023 | 18 | |
| 7 | 2020 | 17 | |
| 8 | 2014 | 14 | |
| 9 | 2022 | 9 | |
| 10 | 2020 | 8 | |
| 11 | 2019 | 8 | |
| 12 | 2018 | 5 | |
| 13 | 2020 | 3 | |
| 14 | 2024 | 2 | |
| 15 | 2025 | 0 |
About Lingdan Chen
Lingdan Chen is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Surgery, Endocrinology, Diabetes and Metabolism and Biochemistry, having authored 15 papers that have together received 280 indexed citations. Recurring topics across this work include Chronic Obstructive Pulmonary Disease (COPD) Research (4 papers), Angiogenesis and VEGF in Cancer (2 papers), Peripheral Artery Disease Management (2 papers), Pulmonary Hypertension Research and Treatments (2 papers), Protease and Inhibitor Mechanisms (1 paper), Eicosanoids and Hypertension Pharmacology (1 paper), Respiratory Support and Mechanisms (1 paper) and Gastrointestinal motility and disorders (1 paper). The work is most often cited by research in Biochemistry (33 citations), Cancer Research (37 citations), Gastroenterology (12 citations), Immunology (42 citations) and Pharmacology (15 citations). Lingdan Chen has collaborated with scholars based in China, United States and Netherlands. Frequent co-authors include Wenju Lu, He-Sheng Luo, Baoping Yu, Mingjie Yuan, Mahinur Bakri, Weiwei Xiao, Zhun Sun, Ping‐Hong Zhou, Guangshuai Jia and Zifeng Wang. Their work appears in journals such as Biochemical and Biophysical Research Communications, Bioscience Reports, Chinese Journal of Natural Medicines, Clinical and Translational Medicine and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.